Luca Issi
Stock Analyst at RBC Capital
(3.87)
# 679
Out of 5,130 analysts
216
Total ratings
48.15%
Success rate
10.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Outperform | $860 → $925 | $788.49 | +17.31% | 3 | Dec 17, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $82 → $95 | $80.30 | +18.31% | 11 | Dec 17, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $52 → $80 | $64.56 | +23.92% | 11 | Dec 11, 2025 | |
| WVE Wave Life Sciences | Upgrades: Outperform | $9 → $27 | $13.84 | +95.09% | 6 | Dec 9, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Sector Perform | $7 → $10 | $9.85 | +1.52% | 3 | Dec 8, 2025 | |
| MRNA Moderna | Maintains: Sector Perform | $28 → $25 | $34.30 | -27.11% | 18 | Nov 21, 2025 | |
| AGIO Agios Pharmaceuticals | Downgrades: Sector Perform | $57 → $28 | $28.41 | -1.44% | 1 | Nov 20, 2025 | |
| KRRO Korro Bio | Downgrades: Sector Perform | $85 → $8 | $9.50 | -15.79% | 8 | Nov 13, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Sector Perform | $42 → $50 | $53.84 | -7.13% | 15 | Nov 11, 2025 | |
| RGNX REGENXBIO | Maintains: Outperform | $17 → $19 | $14.59 | +30.23% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $14 → $9 | $10.38 | -13.29% | 7 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $30 | $17.77 | +68.82% | 4 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $45 | $25.32 | +77.73% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $61 → $72 | $72.37 | -0.51% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $435 → $500 | $398.29 | +25.54% | 28 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $210 → $230 | $202.99 | +13.31% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.71 | +484.80% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $27.30 | -34.07% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $10.54 | +89.75% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.44 | +351.47% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $11.26 | +50.98% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $7.41 | +75.44% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $7.50 | +366.67% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $27.55 | -5.63% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $58.95 | +18.74% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $45.20 | +26.11% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $2.07 | +93.24% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $22.51 | +242.07% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.66 | +743.37% | 5 | Aug 7, 2024 |
argenx SE
Dec 17, 2025
Maintains: Outperform
Price Target: $860 → $925
Current: $788.49
Upside: +17.31%
Ionis Pharmaceuticals
Dec 17, 2025
Maintains: Outperform
Price Target: $82 → $95
Current: $80.30
Upside: +18.31%
Arrowhead Pharmaceuticals
Dec 11, 2025
Maintains: Outperform
Price Target: $52 → $80
Current: $64.56
Upside: +23.92%
Wave Life Sciences
Dec 9, 2025
Upgrades: Outperform
Price Target: $9 → $27
Current: $13.84
Upside: +95.09%
Fulcrum Therapeutics
Dec 8, 2025
Maintains: Sector Perform
Price Target: $7 → $10
Current: $9.85
Upside: +1.52%
Moderna
Nov 21, 2025
Maintains: Sector Perform
Price Target: $28 → $25
Current: $34.30
Upside: -27.11%
Agios Pharmaceuticals
Nov 20, 2025
Downgrades: Sector Perform
Price Target: $57 → $28
Current: $28.41
Upside: -1.44%
Korro Bio
Nov 13, 2025
Downgrades: Sector Perform
Price Target: $85 → $8
Current: $9.50
Upside: -15.79%
CRISPR Therapeutics AG
Nov 11, 2025
Maintains: Sector Perform
Price Target: $42 → $50
Current: $53.84
Upside: -7.13%
REGENXBIO
Nov 7, 2025
Maintains: Outperform
Price Target: $17 → $19
Current: $14.59
Upside: +30.23%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $14 → $9
Current: $10.38
Upside: -13.29%
Nov 6, 2025
Maintains: Outperform
Price Target: $23 → $30
Current: $17.77
Upside: +68.82%
Nov 4, 2025
Maintains: Outperform
Price Target: $65 → $45
Current: $25.32
Upside: +77.73%
Oct 28, 2025
Downgrades: Sector Perform
Price Target: $61 → $72
Current: $72.37
Upside: -0.51%
Sep 19, 2025
Maintains: Outperform
Price Target: $435 → $500
Current: $398.29
Upside: +25.54%
Aug 8, 2025
Maintains: Outperform
Price Target: $210 → $230
Current: $202.99
Upside: +13.31%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.71
Upside: +484.80%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $27.30
Upside: -34.07%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $10.54
Upside: +89.75%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.44
Upside: +351.47%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $11.26
Upside: +50.98%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $7.41
Upside: +75.44%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $7.50
Upside: +366.67%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $27.55
Upside: -5.63%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $58.95
Upside: +18.74%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $45.20
Upside: +26.11%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.07
Upside: +93.24%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $22.51
Upside: +242.07%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.66
Upside: +743.37%